ASCO23

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

ASCO23
May 29, 2025, 09:11 | Blog
Aakash Desai Launches First Podcast Episode at ASCO25 with Oncology News Central
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 7, 2024, 13:38 | Blog
Anand Patel: Imetelstat approved for lower-risk MDS with anemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…
Feb 14, 2024, 18:02 | Blog
Mark Lewis: Dr. Andrew Ko’s observation at ASCO23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX!
Mark Lewis shared on X: “Seems relevant to resurface Dr. Andrew Ko’s observation at ASCO23…
Dec 17, 2023, 03:29 | Blog
Advancing the Battle Against Platinum-Resistant Ovarian Cancer: Promising Strategies from 2023 ASCO & ESMO Meetings
The 2023 ASCO and ESMO meetings provided novel insights for treating platinum-resistant ovarian cancer, a…
Aug 16, 2023, 19:31 | Societies
Mark your calendars for our FIRST live lung cancer journal club discussing updated results from the ADAURA trial - LungCancerRx
Quoting a post from Twitter user "LungCancerRx": "Exciting News! Mark your calendars for our FIRST…
Jul 18, 2023, 20:06 | Blog
I argue that crossover should not be “allowed”- they should either be “mandated” or “prohibited” - Bishal Gyawali
Hot off the press in NatureRevClinOncol! Using examples from trials presented at ASCO23, in this…
Jun 22, 2023, 19:15 | Positive
We are at a pivotal time for treatment innovations in hematological malignancies - Anas Younes
We are at a pivotal time for treatment innovations in hematological malignancies, and our data…
Jun 19, 2023, 18:18 | Career
I rejoined (best!) ASCO International Affairs Committee in capacity as Chair-Elect - Herbert Loong
As ASCO23 ends & we eagerly look forward to ASCO24, I am pleased to announce…
Jun 12, 2023, 04:02 | Blog
I closed my ASCO23 with 65507+ steps- Abdelali (Ali) MAJDI
I closed my ASCO23 with 65507+ steps Every step opened new opportunities to learn, connect, and…
Jun 10, 2023, 11:59 | Blog
An Unforgettable Journey: Reflections on ASCO23 Annual Meeting - Matteo Lambertini
Time to go home after an exciting #ASCO23 annual meeting…I have to admit that when I entered…
Jun 10, 2023, 02:53 | Blog
Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino
Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in…
Jun 8, 2023, 18:38 | Blog
I'm pleased to share three papers in Cancer Discovery- Elizabeth McKenna
I'm pleased to share three papers in #CancerDiscovery that were published simultaneously with posters/presentations at #ASCO23: From the…
Jun 7, 2023, 18:50 | Opinion
Advancements in Cancer Drug Development: Sanofi’s Commitment to Impactful Therapies and Data Sharing at ASCO23
In the past two decades, we have witnessed remarkable advancements in cancer treatment, with groundbreaking…
Jun 4, 2023, 17:42 | Opinion
Putting Patients First: The Crucial Role of Patient Partnership in Cancer Care and Research
"Partnering With Patients: The Cornerstone of Cancer Care and Research" - Reflecting on the ASCO…
Jun 4, 2023, 17:11 | Blog
Reflecting on a Significant Life Milestone: Departing MD Anderson Cancer Center after 15 Years of Dedication
Today marks a significant milestone in my life as I bid farewell to MD Anderson…
All: 15 Posts: 1 - 100
Special Coverage